Open AccessRisk of infections of biological and targeted drugs in patients with spondyloarthritis: meta-analysis of randomized clinical trials
Author(s) -
Lin Hu,
Siliang Man,
Xiaojian Ji,
Yiwen Wang,
Xingkang Liu,
Jiaxin Zhang,
Chuan Song,
Jin Zhu,
Feng Huang
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001928
Subject(s) - medicine , meta analysis , randomized controlled trial , clinical trial , medline , intensive care medicine , biology , biochemistry
Concerns exist regarding the risk of infections in patients with spondyloarthritis (SpA) treated with biologics. We assessed the risk of infections of biological and targeted drugs in patients with SpA by performing a meta-analysis based on randomized controlled trials (RCTs).